Impel Pharma Files for Bankruptcy Under Chapter 11

Impel Pharmaceuticals filed voluntary petitions for relief under Chapter 11 of Title 11 of the USBankruptcy Court for the Northern District of Texas.

• Company entered into a “stalking horse” asset purchase agreement with JN Bidco to sell substantially all of its assets

NOTE: Impel Tumbles, Cites Need to Raise Funds in ‘Very Near Term’

To view the source of this information, click here

To contact the reporter on this story:
Georgi Azar in New York at gazar4@bloomberg.net

To contact the editor responsible for this story:
Sunil Kesur at skesur@bloomberg.net

© 2023 Bloomberg L.P. All rights reserved. Used with permission.